US Stock MarketDetailed Quotes
BNOX Bionomics
- 0.278
- -0.004-1.56%
Close Nov 21 16:00 ET
- 0.280
- +0.002+0.76%
Post 17:32 ET
5.43MMarket Cap-217P/E (TTM)
0.300High0.273Low333.33KVolume0.300Open0.282Pre Close93.87KTurnover1.99%Turnover RatioLossP/E (Static)19.53MShares1.76052wk High0.32P/B4.65MFloat Cap0.17752wk Low--Dividend TTM16.73MShs Float22.000Historical High--Div YieldTTM9.50%Amplitude0.177Historical Low0.281Avg Price1Lot Size
About Bionomics Company
Bionomics Ltd. is a clinical stage biopharmaceutical company, which develops novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders with high unmet medical need. Its lead product candidate is BNC210. The company was founded in 1996 and is headquartered in Eastwood, Australia.
Company Profile
SymbolBNOX
Company NameBionomics
Issue Price12.35
Founded1996
CEODr. Spyros Papapetropoulos, PhD
MarketNASDAQ
Employees24
Securities TypeDR
ADS Ratio1.0 : 180.0
Fiscal Year Ends06-30
Address200 Greenhill Road
CityEastwood
ProvinceSouth Australia (SA)
CountryAustralia
Zip Code5063
Phone61-8-8150-7400
Websitehttp://www.bionomics.com.au
Company Executives
- Name
- Position
- Salary
- Dr. Spyros Papapetropoulos, PhD
- Director, President and Chief Executive Officer
- 919.77K
- Timothy M. Cunningham
- Chief Financial Officer
- --
- Adrian Hinton
- Financial Controller and Principal Accounting Officer
- 299.55K
- Liz Doolin
- Vice President, Clinical Development
- 357.03K
- Alan Fisher
- Chairman of the Board
- 87.00K
- Peter Miles Davies
- Independent Director
- 77.00K
- Dr. Jane Ryan, PhD
- Independent Director
- 86.72K
- David Wilson
- Independent Director
- 87.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data